-
Researchers warn pandemic could delay cancer advances ‘by almost a year’
pharmatimes
December 01, 2020
A new survey has detailed cancer researchers’ concerns that advances for patients could be delayed by nearly 18 months due to the impact of the COVID-19 pandemic.
-
Putting the vulnerable first could end the pandemic faster
expresspharma
December 01, 2020
The role of serendipity in science came to the fore yet again when AstraZeneca and the University of Oxford revealed that a dosing error was at the heart of their COVID-19 vaccine candidate being tested as a half-dose followed by a full dose.
-
Companies should be free to bid on federally funded healthcare contracts: Poll
pharmaceutical-technology
November 25, 2020
Drug products intended for the US market are increasingly being produced at offshore locations prompting legislators to call for reshoring of production.
-
Annual pharma R&D spending in UK climbed 6.9% in 2019
pharmatimes
November 24, 2020
Annual research and development (R&D) spending in the UK’s pharmaceutical sector climbed by 6.9% last year, representing an eight-year high point, according to tax relief specialist Catax.
-
Indian pharma industry: Backbone of Indian economy in the current pandemic
expresspharma
November 23, 2020
Taruna Sondarva, Principal Consultant, IKON Marketing Consultants, outlines how the Indian pharma industry is contributing towards the health of our economy during the pandemic and opines that it will continue to be a growth driver in times to come.
-
Reimagining the next era of doctor engagement
expresspharma
November 20, 2020
The COVID-19 pandemic has significantly altered the way doctors engage with their patients, and in turn, in the way that pharma companies approach doctors.
-
New inquiry launched to assess impact of pandemic on pharmacy services
pharmatimes
November 18, 2020
The All-Party Parliamentary Group on Pharmacy have launched an inquiry into the financial and operational impacts of the COVID-19 pandemic on pharmacy services in the UK.
-
Pre-existing coronavirus antibodies could help protect children against new pandemic strain
worldpharmanews
November 10, 2020
Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection ...
-
Pharma M&A activity up 17 percent year-on-year in H1 of 2020
europeanpharmaceuticalreview
November 06, 2020
A new report has highlighted that despite the pandemic, pharma M&A activity rose but deal value fell in the first half of 2020.
-
Covid-19 cases increase ahead of US presidential election
pharmaceutical-technology
November 04, 2020
Ahead of the US presidential election, Midwestern states in the country are experiencing a record number of Covid-19-related hospitalisations indicating an exponential surge in cases.